Albion News

FT Adviser
Will Fraser-Allen, deputy managing partner of Albion writes in FT Adviser To read the full article please click here read more
The fundraising is expected to target £6 million for each of the six Albion VCTs: Albion Venture Capital Trust PLC, Albion Development VCT PLC, Albion Enterprise VCT PLC, Albion Technology & General VCT PLC, Crown Place VCT PLC and Kings Arms Yard VCT PLC. The Albion VCTs’ combined portfolios have a value of approximately £400 million*, diversified across approximately 60 businesses. The planned top up offers reflect Albion Capital’s confidence in an exciting pipeline of investment opportunities in sectors with long-term growth potential. Over the last five years the Albion VCTs have... read more
Growth Investor of the Year Award
Albion is delighted to have won the award for GROWTH INVESTOR OF THE YEAR 2018   Growth Investor of the Year Award   This is the highest accolade for investment providers, and recognises those demonstrating the best investment performance, the best impact on an investee company, the most innovation in product development, and the most engagement in adviser outreach. The Finalists were: Albion Capital Calculus Capital Deepbridge Capital Mercia Fund Managers MMC Ventures Octopus Investments Oxford Capital Seneca Congratulations to everyone. read more
Dysis Imaging
DYSIS Medical Ltd, the developer of the innovative DYSIS Ultra Colposcope used in cervical cancer screening, announced today the appointment of Darin Hammers as Chief Executive Officer and a member of the board of directors. In addition, Michael Gioffredi was appointed as Chief Commercial Officer. Former CEO Alastair Atkinson will remain with the company and assume the role of Chief Operating Officer. “We believe that Mr. Hammers and Mr. Gioffredi have the right leadership experience and knowledge of the U.S. medical device market to establish DYSIS as the leader in Colposcopy. On behalf of... read more
Hazy AI
Hazy -  has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch. Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCLTechnology Fund which is managed by Albion in collaboration with UCLB. Hazy is a platform that helps businesses identify and anonymise personal data in large datasets whilst maintaining its utility, enabling Hazy’s customers to remain GDPR compliant. Hazy uses ML techniques to capture trends, patterns, and correlations in data in a single, compressed model, and then use this model to generate synthetic data that... read more
G Network
G.Network, Albion Capital and Cube IM are pleased to announce that G.Network and Albion have closed an agreement with Cube Infrastructure Fund II, whereby Cube II is providing an initial GBP60 million of additional funding to G.Network. G.Network is a fast-growing full fibre local access connectivity provider focused on London. G.Network is building and operating new Fibre to the Premises (FTTP) infrastructure across the capital to provide affordable ultra-fast fibre connectivity to businesses and residents. G.Network’s full fibre local access solutions are bridging the gap between old... read more
  London UK, 3 October 2018 Locum’s Nest, the app that connects doctors to locum work in hospitals, has today announced it has raised £3m in further funding from Albion Capital, the leading independent investment manager, and IDO Investments. The new funding takes the total investment in Locum’s Nest to £4.1 million. Locum’s Nest is the mobile-first platform connecting doctors to temporary work in healthcare organisations, while helping hospital staff managers cut out the inefficient and expensive agency middleman. Traditionally, hospitals looking for locum staff to fill empty shifts pay... read more
10 September 2018 – Arecor, the UK-based biopharmaceutical formulation company, has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes. The fundraising was led by Calculus Capital, Albion Capital, and Downing Ventures.  BioScience Managers Limited, the international healthcare investment firm, advised Downing Ventures.Through the application of its technology platform, Arecor is creating faster working, more effective drugs that help progress the creation of the next generation of artificial pancreas systems... read more
Fishmongers' Hall.jpg
Many thanks to all those that joined us at The Fishmongers' Hall for another very successful seminar The slides from the event will be available shortly read more
Funding led by the UCL Technology Fund with participation from: Nationwide Building Society, Pentland, Amadeus Capital Partners and AI Seed Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has announced an additional $1.8 million seed funding led by UCL Technology Fund, alongside Nationwide Building Society, Pentland, Amadeus Capital Partners, AI Seed and other investors. This takes Hazy’s total seed funding to $2.8 million following a $1 million investment from M12 and Notion, awarded to the company in May, after Hazy... read more

Pages